4.4 Article

Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy

Emmanouil Papasavvas et al.

Summary: Accurate characterization of the HIV reservoir is crucial for developing an effective cure, and the intact proviral DNA assay (IPDA) was used to measure HIV in ART-suppressed individuals. Intact provirus was found to be correlated with total and integrated HIV.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus-1

Sharon A. Riddler et al.

Summary: In a Phase Ib study investigating the effects of vesatolimod in adults with HIV-1, the drug was found to be generally well tolerated and immune stimulation was observed at doses above 4 mg, indicating potential for future combination trials in individuals living with HIV.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy

Rajesh T. Gandhi et al.

Summary: Intact, replication-competent proviruses are selectively lost over time during suppressive ART, while defective provirus levels remain stable. The proportion of intact proviruses within the total HIV-1 DNA reservoir decreases over time on ART. Levels of intact proviruses on ART are correlated with total HIV-1 DNA and residual plasma viremia, but not with markers of inflammation or immune activation.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

Natalie N. Kinloch et al.

Summary: The Intact Proviral DNA Assay quantifies intact HIV reservoirs but faces a 28% failure rate due to HIV-1 polymorphism. Within-host HIV-1 diversity poses a challenge to the accuracy of IPDA measurements.

NATURE COMMUNICATIONS (2021)

Article Immunology

Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral Therapy

Shane D. Falcinelli et al.

Summary: This study demonstrates a close relationship between the frequencies of intact proviral DNA measured by IPDA and replication-competent HIV measured by QVOA. IPDA shows promise as a high-throughput approach to estimate changes in the frequency of the replication-competent reservoir.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA

Francesco R. Simonetti et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Biochemistry & Molecular Biology

Recommendations for measuring HIV reservoir size in cure-directed clinical trials

Mohamed Abdel-Mohsen et al.

NATURE MEDICINE (2020)

Article Multidisciplinary Sciences

A quantitative approach for measuring the reservoir of latent HIV-1 proviruses

Katherine M. Bruner et al.

NATURE (2019)

Article Multidisciplinary Sciences

HIV-1 DNA sequence diversity and evolution during acute subtype C infection

Guinevere Q. Lee et al.

NATURE COMMUNICATIONS (2019)

Article Multidisciplinary Sciences

Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART

Nadine Bachmann et al.

NATURE COMMUNICATIONS (2019)

Article Cell Biology

The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation

Melissa-Rose Abrahams et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Article Immunology

Blood biomarkers of expressed and inducible HIV-1

Anthony R. Cillo et al.

Article Multidisciplinary Sciences

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

Erica N. Borducchi et al.

NATURE (2018)

Article Biochemistry & Molecular Biology

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

Marina Caskey et al.

NATURE MEDICINE (2017)

Article Biochemistry & Molecular Biology

Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

Mattia Bonsignori et al.

Article Biochemistry & Molecular Biology

International AIDS Society global scientific strategy: towards an HIV cure 2016

Steven G. Deeks et al.

NATURE MEDICINE (2016)

Article Immunology

Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies

Amanda M. Crooks et al.

JOURNAL OF INFECTIOUS DISEASES (2015)

Article Multidisciplinary Sciences

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

Nicole A. Doria-Rose et al.

NATURE (2014)

Review Multidisciplinary Sciences

Immunologic strategies for HIV-1 remission and eradication

Dan H. Barouch et al.

SCIENCE (2014)

Article Multidisciplinary Sciences

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

Hua-Xin Liao et al.

NATURE (2013)

Article Hematology

In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients

Emanuela Falcinelli et al.

THROMBOSIS AND HAEMOSTASIS (2013)

Article Microbiology

Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies

Susanne Eriksson et al.

PLOS PATHOGENS (2013)

Article Biotechnology & Applied Microbiology

De novo assembly of highly diverse viral populations

Xiao Yang et al.

BMC GENOMICS (2012)

Article Immunology

Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro

Kersten K. Koelsch et al.

JOURNAL OF INFECTIOUS DISEASES (2008)

Article Biochemistry & Molecular Biology

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

JD Siliciano et al.

NATURE MEDICINE (2003)